Loading clinical trials...

Mobile Platform for Optimizing Wellness and Engagement in Recovery | Clinical Trials | Clareo Health

RECRUITINGNA

Mobile Platform for Optimizing Wellness and Engagement in Recovery

NCT07178990•University of Michigan

Summary

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Eligibility

Age

19 - 63 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Participants must be enrolled in the Michigan Medicaid program
•Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
•Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
•Participants must have regular access to a working smartphone and internet connection.
•Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).

Exclusion Criteria

•Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
•Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
•Individuals with substantial cognitive impairment that would interfere with study participation
•Individuals unable to read or understand English
•Individuals experiencing active suicidality or psychosis.
•Individuals with a planned admission to residential treatment or incarceration during the study period.

Locations (1)

University of Michigan

Ann Arbor, Michigan, United States

Key Dates

Start Date

December 8, 2025

Primary Completion Date

July 1, 2027

Completion Date

July 31, 2027

Last Updated

December 12, 2025

Enrollment

ESTIMATED participants

Conditions

Opioid Agonist TreatmentAlcohol Use DisorderOpioid Use Disorder

Interventions

Digital Contingency Management Intervention Arm

BEHAVIORAL

Digital Wellness Arm

BEHAVIORAL

Contacts

Haley Stevens

CONTACT

734-764-9910 hsteve@med.umich.edu

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

NCT05855668

Alcohol Use DisorderCannabis Use Disorder

View study

RECRUITINGPHASE2

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

NCT06651177

Opioid Use DisorderOpioid Use Disorder, Moderate+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 12, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Mobile Platform for Optimizing Wellness and Engagement in Recovery

Inclusion Criteria

Exclusion Criteria

Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder

Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD)

Using Facebook to Support Opioid Recovery Among American Indian Women